SLDB
Closed
Solid Biosciences Llc
4.6
-0.3 (-6.16%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.87
Day's Range: 4.5 - 4.82
Send
sign up or login to leave a comment!
When Written:
4.76
Solid Biosciences LLC is a biotechnology company that focuses on developing therapies for Duchenne muscular dystrophy (DMD). The company was founded in 2013 by Ilan Ganot, who has a son with DMD. Solid Biosciences LLC is headquartered in Cambridge, Massachusetts, and has a team of scientists, researchers, and clinicians who are dedicated to finding a cure for DMD.
The company's lead product candidate is SGT-001, a gene therapy that aims to treat DMD by delivering a functional copy of the dystrophin gene to muscle cells. Solid Biosciences LLC has completed several clinical trials of SGT-001, and the therapy has shown promising results in improving muscle function and reducing the severity of DMD symptoms.
In addition to its work on SGT-001, Solid Biosciences LLC is also researching other therapies for DMD, including gene editing and exon skipping. The company has partnerships with several academic institutions and other biotech companies to advance its research and development efforts.
Solid Biosciences LLC is a privately held company and has raised over $200 million in funding from investors, including RA Capital Management, Bain Capital Life Sciences, and Perceptive Advisors.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company's lead product candidate is SGT-001, a gene therapy that aims to treat DMD by delivering a functional copy of the dystrophin gene to muscle cells. Solid Biosciences LLC has completed several clinical trials of SGT-001, and the therapy has shown promising results in improving muscle function and reducing the severity of DMD symptoms.
In addition to its work on SGT-001, Solid Biosciences LLC is also researching other therapies for DMD, including gene editing and exon skipping. The company has partnerships with several academic institutions and other biotech companies to advance its research and development efforts.
Solid Biosciences LLC is a privately held company and has raised over $200 million in funding from investors, including RA Capital Management, Bain Capital Life Sciences, and Perceptive Advisors.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!